Antiserum, Cf, Psittacosis (Chlamydia Group)
The Psittacosis (Chlamydia Group) CF (Complement Fixation) Antiserum is a reference reagent used to validate complement fixation tests for the serological detection of Chlamydia group antibodies, supporting the diagnosis of psittacosis (parrot fever), an avian-transmitted respiratory infection caused by Chlamydia psittaci. It is classified as FDA Class 1 (lowest risk) and is subject only to general controls. The product code is GPT, regulated under 21 CFR 866.3120 in the Microbiology specialty. This device is eligible for third-party 510(k) review.
Research product code GPT in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- GPT
- Device Class
- FDA class 1
- Regulation Number
- 866.3120
- Medical Specialty
- Microbiology
- Review Panel
- MI
- Submission Type
- 1
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K810856 | DIRECT IMMUNOFLUOR. ANTIBODY TEST KIT | May 05, 1981 | Substantially Equivalent | Bartels Immunodiagnostic Supplies, Inc. |